» Articles » PMID: 383616

Cryptococcal Culture Filtrate Antigen for Detection of Delayed-type Hypersensitivity in Cryptococcosis

Overview
Journal Infect Immun
Date 1979 Jul 1
PMID 383616
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies on a cryptococcal culture filtrate (CneF) antigen have shown that the antigen is useful in detecting delayed-type hypersensitivity and that it is specific for Cryptococcus. This study further defined one more parameter of specificity, showing that the CneF antigen does not elicit delayed-type hypersensitivity responses in Cryptococcus albidus-sensitized guinea pigs. When the crude CneF antigen was subjected to ultrafiltration fractionation, the skin test active components were found to be in the 50,000 or greater molecular weight range fraction. The concentrated retentates of the XM50 ultrafiltration membrane were more sensitive antigens than the crude CneF antigens. Further fractionation of the XM50 retentate using 3% acrylamide gel electrophoresis separated the antigen into two bands. One band, the P fraction, migrated only a short distance into the gel; the fraction was carbohydrate-like and did not elicit significant skin test responses in sensitized guinea pigs. The other band, G fraction, appeared with the tracking dye, was glycoprotein-like, and elicited significantly positive skin tests in sensitized guinea pigs. G fractions prepared using three different serotypes of Cryptococcus neoformans elicited similar size indurations when used in skin testing guinea pigs sensitized with either the homologous serotype isolated of C. neoformans or the heterologous serotype isolate.

Citing Articles

Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Jain N, Li L, Hsueh Y, Guerrero A, Heitman J, Goldman D Infect Immun. 2008; 77(1):128-40.

PMID: 18955480 PMC: 2612268. DOI: 10.1128/IAI.01079-08.


Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Herring A, Lee J, McDonald R, Toews G, Huffnagle G Infect Immun. 2002; 70(6):2959-64.

PMID: 12010985 PMC: 127967. DOI: 10.1128/IAI.70.6.2959-2964.2002.


Identification and cloning of a cryptococcal deacetylase that produces protective immune responses.

Biondo C, Beninati C, Delfino D, Oggioni M, Mancuso G, Midiri A Infect Immun. 2002; 70(5):2383-91.

PMID: 11953374 PMC: 127888. DOI: 10.1128/IAI.70.5.2383-2391.2002.


Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans.

Pietrella D, CHERNIAK R, Strappini C, Perito S, Mosci P, Bistoni F Infect Immun. 2001; 69(5):2808-14.

PMID: 11292692 PMC: 98228. DOI: 10.1128/IAI.69.5.2808-2814.2001.


The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice.

Mandel M, Grace G, Orsborn K, Schafer F, Murphy J, Orbach M Infect Immun. 2000; 68(11):6196-201.

PMID: 11035725 PMC: 97699. DOI: 10.1128/IAI.68.11.6196-6201.2000.


References
1.
LOWRY O, ROSEBROUGH N, FARR A, RANDALL R . Protein measurement with the Folin phenol reagent. J Biol Chem. 1951; 193(1):265-75. View

2.
Dykstra M, Friedman L . Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosis. Infect Immun. 1978; 20(2):446-55. PMC: 421876. DOI: 10.1128/iai.20.2.446-455.1978. View

3.
Cauley L, Murphy J . Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect Immun. 1979; 23(3):644-51. PMC: 414213. DOI: 10.1128/iai.23.3.644-651.1979. View

4.
Zacharius R, Zell T, Morrison J, Woodlock J . Glycoprotein staining following electrophoresis on acrylamide gels. Anal Biochem. 1969; 30(1):148-52. DOI: 10.1016/0003-2697(69)90383-2. View

5.
Murphy J, Gregory J, LARSH H . Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect Immun. 1974; 9(2):404-9. PMC: 414817. DOI: 10.1128/iai.9.2.404-409.1974. View